Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer
Fossa, S.D.; Paus, E.
Progress in Clinical and Biological Research 203: 121
1985
ISSN/ISBN: 0361-7742 PMID: 2421325 Document Number: 262298
Document emailed within 1 workday
Related Documents
Miki, T.; Saki, S.; Kotake, T. 1994: The role of salvage surgery following chemotherapy in advanced testicular cancer Hinyokika Kiyo. Acta Urologica Japonica 40(10): 951-955Ondrus, D.; Hornák, M.; Matoska, J. 1993: Neo-adjuvant chemotherapy with delayed orchiectomy in patients with advanced germ cell testicular cancer Neoplasma 40(3): 189-192
Tonkin, K.S.; Rustin, G.J.; Wignall, B.; Paradinas, F.; Bennett, M. 1989: Successful treatment of patients in whom germ cell tumour masses enlarged on chemotherapy while their serum tumour markers decreased European Journal of Cancer and Clinical Oncology 25(12): 1739-1743
Ikeda, I.; Shuin, T.; Yao, M.; Kubota, Y.; Hosaka, M. 1993: New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases Hinyokika Kiyo. Acta Urologica Japonica 39(3): 237-242
Mikami, K.; Nakagawa, S.; Sugimoto, K.; Nomoto, T.; Urano, S.; Watanabe, H.; Iwamoto, N.; Yamazaki, S.; Hiratake, Y.; Maegawa, M. 1997: Clinical results of combination chemotherapy with cisplatin, vinblastine and bleomycin (pvb) for advanced testicular cancer: evaluation of risk criteria Hinyokika Kiyo. Acta Urologica Japonica 43(8): 561-566
Kolberg, H.C.; Villena-Heinsen, C.; Deml, M.M.; Kraemer, S.; Diedrich, K.; Friedrich, M. 2005: Relationship between chemotherapy with paclitaxel, cisplatin, vinorelbine and titanocene dichloride and expression of proliferation markers and tumour suppressor gene p53 in human ovarian cancer xenografts in nude mice European Journal of Gynaecological Oncology 26(4): 398-402
Solé-Balcells, F.; Villavicencio, H.; Germá, R. 1989: Retroperitoneal lymph node dissection (RPLND) post chemotherapy for non-seminomatous testicular neoplasms: what is the significance of residual masses at scanner control after chemotherapy and should they be removed? Progress in Clinical and Biological Research 303: 759-762
Al-Saleh, K.; Abd El-Aziz, N.; Ali, A.; Abo Zeed, W.; Salah, T.; Elsamany, S.; Rasmy, A.; El Farargy, O.; Husain, S.; Al-Rikabi, A.; Alsaeed, E.; Aldiab, A.; Abd El-Warith, A. 2019: A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC) Gulf Journal of Oncology 1(30): 33-42
Gargano, G.; Correale, M.; Abbate, I.; Falco, G.; De Frenza, N.; Lorusso, V.; De Lena, M.; De Leonardis, A. 1990: The role of tumour markers in ovarian cancer Clinical and Experimental Obstetrics and Gynecology 17(1): 23-29
Sparholt, M.H.; Høgdall, E.; Høgdall, C.K. 2009: Tumour markers in epithelial ovarian cancer Ugeskrift for Laeger 171(48): 3505-3509
Higgins, C. 1996: Use of tumour markers in cancer diagnosis and treatment Nursing Times 92(16): 36-37
Hidalgo, J.; Rodríguez, A.; Canalias, J.; Muntané, M.Jesús.; Huerta, M.Victoria.; Carrasco, N.; Vesa, J. 2008: Segmental testicular infarction vs testicular tumour: the usefulness of the excisional frozen biopsy Archivos Espanoles de Urologia 61(1): 92-93
Sato, A.; Yamamoto, W.; Takebuchi, K.; Hiratsuka, N.; Tadokoro, K.; Ushio, J. 2001: Home chemotherapy and/or outpatient chemotherapy for patient with advanced gastric cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 4): 616-620
Kato, M.; Kinoshita, K.; Sawa, T.; Yoshimitsu, S.; Tomita, F.; Takano, Y.; Segawa, M.; Ohyama, S.; Yonemura, Y.; Miwa, K. 1990: Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(3 Part 1): 391-396
Eskelinen, M.; Kataja, V.; Hämäläinen, E.; Kosma, V.M.; Penttilä, I.; Alhava, E. 1997: Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer Anticancer Research 17(2b): 1231-1234
Ariffin, N.A.; Nason, G.J.; Omer, S.I.; Considine, S.W.; Sweeney, P.; Power, D.G. 2017: Post-Chemotherapy Retroperitoneal Lymph Node Dissection in Patients with Non-Seminomatous Germ Cell Tumour (NSGCT) Irish Medical Journal 110(10): 647
Bosl, G.J. 1979: Chorionic gonadotrophin and alpha-fetoprotein markers for testicular cancer Minnesota Medicine 62(7): 507-508
Donohue, J.P.; Rowland, R.G. 1985: Treatment alternatives in advanced testicular cancer Progress in Clinical and Biological Research 203: 593-613
Block, N.L. 1974: Chemotherapy of testicular cancer Journal of the Florida Medical Association 61(11): 817-820
Xiao, Y.-Y.; Zhan, P.; Yuan, D.-M.; Liu, H.-B.; Lv, T.-F.; Shi, Y.; Song, Y. 2013: Chemotherapy plus Vandetanib or chemotherapy alone in advanced non-small cell lung cancer: a meta-analysis of four randomised controlled trials Clinical Oncology 25(1): E7